These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 11880682)
1. The problem of biological weapons: next steps for the nation. O'Toole T Public Health Rep; 2001; 116 Suppl 2(Suppl 2):108-11. PubMed ID: 11880682 [No Abstract] [Full Text] [Related]
2. National leadership in confronting bioterrorism: 1. Hamre JJ Public Health Rep; 2001; 116 Suppl 2(Suppl 2):112-5. PubMed ID: 11880683 [No Abstract] [Full Text] [Related]
3. Legal issues surrounding public health emergencies. Fidler DP Public Health Rep; 2001; 116 Suppl 2(Suppl 2):79-86. PubMed ID: 11880678 [No Abstract] [Full Text] [Related]
4. Time is running out. Congress' budget inaction considered a threat to bioterrorism preparedness. Tieman J Mod Healthc; 2002 Oct; 32(43):10. PubMed ID: 12436770 [No Abstract] [Full Text] [Related]
5. Reducing the bioweapons threat: international collaboration efforts. Eitzen EM Public Health Rep; 2001; 116 Suppl 2(Suppl 2):17-8. PubMed ID: 11880663 [No Abstract] [Full Text] [Related]
6. Bioterrorism, public health, and civil liberties. Annas GJ N Engl J Med; 2002 Apr; 346(17):1337-42. PubMed ID: 11973377 [No Abstract] [Full Text] [Related]
7. National leadership in confronting bioterrorism: 2. Kennedy EM Public Health Rep; 2001; 116 Suppl 2(Suppl 2):116-8. PubMed ID: 11880684 [No Abstract] [Full Text] [Related]
8. National disaster medical system. Knouss RF Public Health Rep; 2001; 116 Suppl 2(Suppl 2):49-52. PubMed ID: 11880672 [No Abstract] [Full Text] [Related]
9. Combating bioterrorism with bioengineering. Laxminarayan S; Kun LG IEEE Eng Med Biol Mag; 2002; 21(5):21, 23-7. PubMed ID: 12405054 [No Abstract] [Full Text] [Related]
10. Epidemic response scenario: decision making in a time of plague. O'Toole T; Inglesby TV Public Health Rep; 2001; 116 Suppl 2(Suppl 2):92-103. PubMed ID: 11880680 [No Abstract] [Full Text] [Related]
11. Observations from the Top Off exercise. Inglesby TV Public Health Rep; 2001; 116 Suppl 2(Suppl 2):64-8. PubMed ID: 11880675 [No Abstract] [Full Text] [Related]
12. Biodefense: who's in charge? Sutton V Health Matrix Clevel; 2003; 13(1):117-58. PubMed ID: 14569660 [No Abstract] [Full Text] [Related]
13. Legal preparedness for bioterrorism. Matthews GW; Benjamin G; Mills SP; Parmet W; Misrahi JJ J Law Med Ethics; 2002; 30(3 Suppl):52-6. PubMed ID: 12508503 [TBL] [Abstract][Full Text] [Related]
15. Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006. Schuler A Biosecur Bioterror; 2005; 3(2):94-101. PubMed ID: 16000040 [TBL] [Abstract][Full Text] [Related]
16. US biodefense--shocking and awful. Nat Biotechnol; 2007 Jun; 25(6):603. PubMed ID: 17557081 [No Abstract] [Full Text] [Related]
17. Pharmaceuticals and the strategic national stockpile program. Stewart A; Cordell GA Dent Clin North Am; 2007 Oct; 51(4):857-69, vii. PubMed ID: 17888762 [TBL] [Abstract][Full Text] [Related]
18. Health care's counterterrorism efforts: what's being done and what isn't. Coates V Manag Care; 2003 Nov; 12(11 Suppl):19-21. PubMed ID: 14669389 [No Abstract] [Full Text] [Related]